Replies to post #670355 on NorthWest Biotherapeutics Inc (NWBO)

[evanstony]

have a solid set of patent moats to protect the company and investors.

this is now going to be painfully obvious...to the competition and the shorts

[Chiugray]

Biosectinvestor, I do remember you showing that Flaskworks would not require an additional clinical trial for approval as long as comparability was done prior to regulatory approval. I believe people will again be surprised that, in the end NWBO is getting everything done right. Thanks again for this informative post!